Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 283

TVM Capital Healthcare expands its Singapore healthcare investment practice

Submitted 16/11/2020 - 10:39am

TVM Capital Healthcare, a global private equity and growth capital firm dedicated to emerging markets, has announced two team additions. 

Raymond Rudianto, Partner, and Mervyn See, Principal, joined the Singapore-based investment team to support Dr Helmut Schuehsler, CEO & Chairman, Hoda Abou-Jamra, Founding Partner, Chung Pit Lee, Chief Financial Officer, and the regional team of senior healthcare advisors.

 
These latest editions to the team come after TVM Capital Healthcare became a Registered Fund Management Company (RFMC) with the Monetary Authority of Singapore (MAS).
 
Abou-Jamra says: “Receiving the RFMC status from MAS is an important step for us to invest growth capital in aspiring healthcare companies in the region, since Singapore is an important hub for our investment activities in SEA. Consequently, I am happy to welcome Raymond and Mervyn to our team as their extensive regional experience and expertise will bolster and complement the value we will add to our investments.”
 
Rudianto adds: “Having worked on many healthcare deals throughout Southeast Asia, I’m looking forward to helping the region’s healthcare sector thrive. The firm’s investment focus on specialty healthcare companies with ambitious growth plans will positively impact the region’s ability to provide high quality healthcare services to patients in need and provide investors with good returns. I look forward to playing an active part in that.”
 
Rudianto joins TVM Capital Healthcare from PT Aldiracita Sekuritas, where he was CEO. He gained significant professional experience at Baring Private Equity Asia, where he led Indonesia and SEA Healthcare. Raymond also currently sits as a board member of PT Nitrasanata Dharma (Jakarta Eye Center), the largest ophthalmology hospital chain in Indonesia. Previously, Raymond served as CEO, Indonesia, for Rothschild & Co and has also held positions at JP Morgan, Morgan Stanley, The Boston Consulting Group and McKinsey & Co Raymond will utilize his experience spanning over 23 years in the region to enhance the operational efficiency of innovative healthcare companies across Southeast Asia, while further strengthening the existing team across the SEA market. Raymond will also draw upon the experience of TVM Capital Healthcare’s skilled investment team and an extensive network of Senior Advisors, who have each established a solid track record in the region’s healthcare industry.
 
Mervyn See joins from Sumitomo Mitsui Banking Corporation (SMBC) where he was the healthcare sector lead driving the growth of SMBC’s investment banking business with healthcare clients, supporting them on healthcare M&A transactions and other strategic corporate finance initiatives. In previous tenures, Mervyn was at IHH Healthcare, one of the largest hospital groups in Asia, an Indonesian family office with global operations, and an analyst at Quadria Capital, where he focused on private equity investments in early to growth stage healthcare companies.

Tags Moves & Appointments

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.